Gorlin Syndrome, a rare genetic disorder causing recurrent basal cell carcinomas and other health challenges, requires constant treatment—but with so few existing therapies, what options are available for patients seeking relief? More research is urgently needed to find better treatments, and our clinical trials are paving the way, offering hope for more effective, less burdensome solutions.